What Arcus Biosciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 1 | 42 |
| Total trades | 2 | 63 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 2,827 | 363,058 |
| Disposed | 2,827 | 632,953 |
| Net activity | +0 | −269,895 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Azoy Alexander | Chief Accounting Officer | Aug 21 | Disclosed 10b5-1 sale · S | −2,827 | $30.00 | −$84.8K | 39,581 |
| Azoy Alexander | Chief Accounting Officer | Aug 21 | Exercise / conversion · M | +2,827 | $15.44 | +$43.6K | 42,408 |
| Jaen Juan C. | President | Jul 10 | Disclosed 10b5-1 sale · S | −268 | $29.40 | −$7.88K | 822,240 |
| Jaen Juan C. | President | Jul 10 | Disclosed 10b5-1 sale · S | −19,799 | $28.61 | −$566K | 822,508 |
| Jaen Juan C. | President | Jul 09 | Disclosed 10b5-1 sale · S | −48,502 | $30.05 | −$1.46M | 842,307 |
| Jaen Juan C. | President | Jun 24 | Disclosed 10b5-1 sale · S | −6,431 | $29.66 | −$191K | 890,809 |
| Jaen Juan C. | President | Jun 23 | Disclosed 10b5-1 sale · S | −1,697 | $28.06 | −$47.6K | 897,240 |
| Jaen Juan C. | President | Jun 23 | Disclosed 10b5-1 sale · S | −14,067 | $27.69 | −$389K | 898,937 |
| Jaen Juan C. | President | Jun 22 | Disclosed 10b5-1 sale · S | −9,236 | $27.03 | −$250K | 913,004 |
| Machado Clarence Patrick | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 44,300 |
| Lacey David L. | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 76,652 |
| Lambert Nicole | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 43,000 |
| Ribas Antoni | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 44,300 |
| Falberg Kathryn E | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 44,300 |
| Perlman Andrew J | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 48,325 |
| Kaneko Yasunori | Director | Jun 11 | Grant / award · A | +5,700 | — | — | 25,700 |
| Tang Carolyn C. | General Counsel | Jun 11 | Exercise / conversion · M | +34,090 | $2.57 | +$87.7K | 184,607 |
| Azoy Alexander | Chief Accounting Officer | Jun 01 | Disclosed 10b5-1 sale · S | −2,562 | $25.77 | −$66K | 39,581 |
| Goeltz Ii Robert C. | Chief Financial Officer | May 11 | Disclosed 10b5-1 sale · S | −7,763 | $25.63 | −$199K | 84,161 |
| Rosen Terry J | Chief Executive Officer | Jan 23 | Grant / award · A | +79,000 | — | — | 2,236,409 |
Loading...
